Saudi healthtech Aumet closes $12 million Series A for hospital AI

Published: 2026-05-13T09:39:58.000Z

Aumet has closed a $12 million Series A led by Emkan Capital to scale its AI-first procurement operating system for healthcare. The platform cut over JOD 2.3 million in medication waste at Jordan's largest hospital in one year.

Healthcare supply chains across the Middle East are broken in ways that are expensive, persistent, and largely invisible to the patient but deeply felt by every hospital administrator, pharmacy manager, and ministry of health official trying to run a functioning system. Medication waste, inconsistent supply, fragmented procurement cycles, and decisions made on incomplete data are not edge cases. They are the default operating conditions for most healthcare institutions across the region. Aumet was founded in 2016 to fix exactly this, and its $12 million Series A round led by Emkan Capital with participation from SABAH.fund is the most significant validation yet that the market agrees the problem is real and the solution is working. Aumet is building what it describes as an AI-first procurement operating system for healthcare, a platform that powers procurement, inventory management, and decision-making across the entire healthcare ecosystem from individual pharmacies to national health systems. The company's CEO and co-founder Yahya Aqel has been consistent about the core insight behind the business: healthcare supply chains do not suffer from a lack of supply. They suffer from a lack of intelligence. The platform addresses that by replacing manual procurement cycles with AI-driven automation, predictive analytics, and real-time data integration across the full chain of manufacturers, distributors, and healthcare providers. The enterprise version of the product, Aumet's most advanced deployment, was first implemented at Al-Bashir Hospital, the largest hospital in Jordan, in collaboration with the Ministry of Health and the Ministry of Digital Economy and Entrepreneurship. The outcomes from that deployment are the kind of numbers that open government doors. The AI Procurement OS reduced medication waste significantly at the hospital level, translating into over JOD 2.3 million in savings in a single year. That is not a pilot result. It is a production-scale proof point that the platform delivers measurable financial impact in the most demanding institutional healthcare environments. Presight, a leading AI company based in Abu Dhabi, also signed an agreement with Aumet to scale the system across Jordan's public healthcare system, extending the model beyond a single hospital deployment to a national infrastructure level. Aumet currently operates across Saudi Arabia, the wider GCC, Jordan, Egypt, and France, giving it a geographic footprint that spans both the Gulf's high-income institutional healthcare market and the larger-volume emerging markets of North Africa and the Levant. The Series A capital will go toward AI expansion, deeper enterprise deployments, and accelerating regional growth across these markets. Qatar is explicitly on the near-term roadmap, with the company planning to hire a dedicated business development team there and tap into the technical talent available through local universities. Emkan Capital's view on the investment was direct. The firm described Aumet as building what it believes is the foundational operating system for healthcare supply chains in emerging markets, a framing that positions the company not as a sector-specific SaaS vendor but as infrastructure. That distinction matters for valuation, for commercial strategy, and for how deeply the platform can embed itself within the institutional relationships it targets. Abbas Kazmi from SABAH.fund pointed to founder-market fit as the central investment thesis, citing the team's deep expertise, regional insight, and technology-driven approach as the combination that sets Aumet apart in a sector where many companies have tried to solve procurement inefficiency without the combination of AI capability and genuine operational experience that this team brings. For the broader MENA healthtech ecosystem, Aumet's Series A lands at a moment when institutional healthcare AI is moving from experimental to essential. Saudi Arabia's Vision 2030 healthcare agenda, the UAE's push for smart hospital infrastructure, and the region's growing awareness of chronic disease burden are all creating demand for exactly the kind of system-level intelligence Aumet provides. With more than 2,000 hospitals across Saudi Arabia, the UAE, and Egypt alone, the addressable market for a platform that can demonstrate the kind of savings Aumet delivered at Al-Bashir is not a niche opportunity. It is a category-defining one.